Myopia Control for Children in Singapore: A Complete Parent's Guide

Singapore has one of the highest rates of myopia in the world. By the time a child reaches Primary 6 — usually at around 12 years old — 65% are already myopic. Among young adults in Singapore, the figure rises to 83%. These are not just spectacle prescriptions; high myopia (typically defined as −6.00 D or more) carries lifelong risks of retinal detachment, glaucoma, macular degeneration, and other sight-threatening complications. With up to 20% of Singapore children now developing high myopia — roughly double the proportion from a decade ago — the question for parents is no longer whether to act, but how.

This guide explains what myopia progression looks like, why early intervention matters, and the main evidence-based treatment options available in Singapore today.

Why Myopia Progresses Faster in Asian Children

Myopia in children is driven primarily by axial elongation — the eyeball grows too long, causing light to focus in front of the retina rather than on it. Asian children, including those in Singapore, experience faster axial elongation than their Caucasian peers.

Research from Hong Kong found that myopic children aged 6–8 experience median annual axial growth of at least 0.30 mm, slowing to around 0.20 mm per year until ages 12–13. A compiled analysis of 20 randomised controlled trials found that Asian children with untreated myopia progress at approximately −0.82 D per year on average. Progression typically stabilises around age 16–17, meaning a child who becomes myopic at age 6 has over a decade of potential worsening ahead of them.

The practical implication is stark: the earlier myopia develops, the higher the final prescription is likely to be. Onset before age 8 is associated with significantly higher adult myopia. This is why optometrists in Singapore increasingly recommend active management from the moment myopia is detected, rather than simply updating spectacle prescriptions year after year.

Genetic factors play a significant role — having one myopic parent roughly doubles a child's risk, and having two myopic parents raises it to 50% or higher. But environmental factors are equally important. Prolonged near work, especially screen time and reading in low light, combined with insufficient time spent outdoors are the primary modifiable drivers.

The Role of Outdoor Time

Before exploring clinical interventions, it is worth emphasising that outdoor time is the most robustly evidenced preventive measure for delaying myopia onset. Singapore's own National Myopia Prevention Programme (NMPP), which began in 2001 under the Health Promotion Board (HPB), incorporates outdoor activity as a central recommendation.

The mechanism is not fully understood but is thought to involve bright light stimulating the release of dopamine in the retina, which slows axial elongation. Studies have consistently shown that approximately two hours of outdoor time per day is associated with delayed onset of myopia in primary school children. The results are visible at a population level: since the NMPP's inception, myopia prevalence in Primary 1 children has decreased and stabilised at around 26% in 2023, meeting the programme's target of 30% or below.

However, once myopia has already developed, outdoor time alone is insufficient to stop progression. At that point, clinical intervention is warranted.

Myopia Control Treatment Options Available in Singapore

Singapore is fortunate to have access to the full spectrum of evidence-based myopia control therapies. The Singapore National Eye Centre (SNEC) and many private optometry practices offer these options. Here is what the current evidence shows.

1. Low-Dose Atropine Eye Drops

Atropine is a muscarinic antagonist that has been used clinically to slow myopia progression since the 1970s. SNEC has used atropine therapy for childhood myopia for more than 20 years, and it remains one of the most widely prescribed interventions in Singapore today.

The key insight from the landmark ATOM studies and subsequent research is that lower doses achieve meaningful control with substantially fewer side effects. At 0.01% concentration, atropine produces minimal pupil dilation, almost no near-vision blur, and negligible photophobia — meaning most children experience no lifestyle disruption at all. Higher concentrations (0.025%, 0.05%) offer greater effect but increase the likelihood of light sensitivity and difficulty with close work.

A 2025 randomised clinical trial published in JAMA Ophthalmology compared 0.04% atropine, 0.01% atropine, and orthokeratology in children aged 8–15. The 0.04% concentration was superior to the others in reducing axial elongation (difference of 0.18 mm over the study period compared with 0.01% atropine), though with a higher incidence of photophobia. Most Singapore practitioners begin at 0.01% and escalate only if progression continues.

What parents should know: Atropine drops are instilled once nightly in each eye. They do not correct vision — the child still wears spectacles or contact lenses for their refractive error. Response should be monitored every six months with refraction measurements and, ideally, axial length measurement to track the actual growth of the eye rather than just the prescription number.

2. Orthokeratology (Ortho-K)

Orthokeratology involves wearing specially designed rigid gas-permeable contact lenses overnight. During sleep, these lenses gently flatten the central cornea, producing clear daytime vision without spectacles or contact lenses. The peripheral retinal defocus created by the reshaped cornea is also believed to send a biochemical signal that slows axial elongation.

Multiple peer-reviewed studies have shown that Ortho-K reduces axial elongation by approximately 40–50% compared to single-vision spectacles. A direct comparison study found that orthokeratology and 0.01% atropine achieve similar myopia control efficacy — both significantly better than conventional glasses alone.

Ortho-K is generally suitable for children aged 8 and above who can manage the lens-handling process. The lenses need to be professionally fitted by an experienced optometrist and reviewed regularly. Compliance is critical: missing nights results in blurred daytime vision and a reduced treatment effect.

What parents should know: Ortho-K lenses require careful hygiene and regular replacement. The risk of microbial keratitis is real but remains low with proper technique. The treatment is fully reversible — if lenses are stopped, the cornea returns to its original shape within a few days.

3. Combination Therapy: Atropine + Ortho-K

The strongest evidence for myopia control efficacy comes from combination therapy. A well-cited randomised trial found that children receiving both 0.01% atropine and Ortho-K progressed at only −0.14 D per year, compared to −0.86 D per year in the control group receiving no active treatment — a six-fold difference in progression rate.

A 2025 study published in Scientific Reports further confirmed that sequential addition of escalating atropine concentrations to Ortho-K enhanced the effect: adding 0.01%, 0.025%, and 0.05% atropine to Ortho-K reduced annual axial elongation by 28.4%, 31.4%, and 39.4% respectively compared to Ortho-K monotherapy.

Combination therapy is typically considered for children who show rapid progression on monotherapy or who have particularly high parental myopia, suggesting a stronger genetic drive.

4. Myopia Control Spectacle Lenses

For children who are not ready for contact lenses — or who prefer the simplicity of glasses — a new generation of spectacle lens designs offers meaningful control. Options available in Singapore include:

DIMS (Defocus Incorporated Multiple Segments) — developed by The Hong Kong Polytechnic University and commercially available as MiYOSMART by Hoya. Clinical trials showed approximately 52% reduction in progression compared to standard single-vision lenses over two years.
H.A.L.T (Highly Aspherical Lenslet Target) — Essilor's Stellest lenses, using a constellation of aspherical lenslets to create a volume of myopic defocus.
CARE (Cylindrical Annular Refractive Element) lenses — another peripheral defocus design available in the region.

These lenses are non-invasive, easy to wear, and appropriate from the onset of myopia. They are a reasonable first step while a child develops the maturity for contact lens wear.

5. Multifocal and Dual-Focus Soft Contact Lenses

For older children or teenagers who prefer soft contact lenses, dual-focus and multifocal designs are another evidence-based option. CooperVision's MiSight 1-day lens has been specifically approved for myopia control and shows approximately 52% reduction in axial elongation compared to standard single-vision lenses in multi-year clinical trials. These daily disposable lenses eliminate the cleaning burden and are suitable for active children.

What Is Not Currently Available in Singapore

Repeated Low Level Red Light (RLRL) therapy is a novel, non-invasive approach — children look into a device emitting low-level red light for a few minutes per day — showing very promising results in studies from China. However, as of the time of writing, it has not been approved by Singapore's Health Sciences Authority (HSA). Parents should be cautious about any service offering this treatment locally before HSA approval is granted.

How to Choose the Right Treatment for Your Child

There is no universally "best" myopia control intervention — the right treatment depends on the individual child and their clinical profile. Optometrists typically consider:

Age and maturity — can the child safely manage contact lenses? Ortho-K typically requires children to be 8 or older with good hand hygiene.
Rate of progression — faster progressors (more than 0.75 D per year) benefit from more aggressive approaches.
Current prescription — children at higher risk of reaching high myopia (typically those already at −2.00 D or more before age 10) benefit most from early combination therapy.
Parental myopia — two myopic parents signals a stronger genetic drive and warrants proactive management.
Lifestyle — a child who plays sports regularly may find Ortho-K attractive for the freedom of glasses-free days.

Regular review every four to six months is essential. The two primary markers optometrists track are refraction (change in dioptres) and axial length (change in millimetres). A change of more than 0.25–0.30 mm in axial length per year is generally considered clinically significant and should prompt re-evaluation of the treatment strategy. Axial length is increasingly regarded as the gold-standard measure because it directly reflects the physical growth of the eye, rather than the optical prescription which can fluctuate.

What to Expect at a Myopia Management Appointment

A structured myopia management visit in Singapore typically includes:

Distance and near visual acuity — checking how clearly the child can see at various distances.
Cycloplegic or non-cycloplegic refraction — measuring the refractive error accurately, often with cyclopentolate drops to relax accommodation in younger children.
Axial length measurement — using a biometer such as the IOLMaster or Lenstar to measure the physical length of the eye.
Slit-lamp examination — checking the front of the eye for any signs of lens-related issues (important for Ortho-K wearers).
Treatment review — comparing current measurements against previous visits to assess the rate of progression and effectiveness of the current intervention.

If you are visiting an optometrist for the first time specifically for myopia management, it helps to bring previous spectacle prescriptions and any records of past eye examinations so the optometrist can assess the trajectory of progression.

Tracking Your Child's Myopia Progression

Understanding whether your child's myopia is progressing faster or slower than expected requires context. The CarrotByte Myopia Progression Calculator lets you estimate expected progression for a child of a given age and current prescription across different management approaches — from no treatment to orthokeratology or atropine.

Use the free Myopia Progression Calculator →

If you are concerned about your child's risk profile — family history, time spent outdoors, screen habits — the Myopia Risk Calculator provides a simple, evidence-based assessment to help you have a more informed conversation with your optometrist.

Use the free Myopia Risk Calculator →

You can also use the Eye Care Directory to find optometrists near you in Singapore who offer myopia management services including Ortho-K and atropine therapy.

Find a myopia management optometrist →

Key Takeaways for Singapore Parents

Singapore has among the world's highest myopia rates — 65% of children are myopic by Primary 6, rising to 83% in young adults.
Myopia is not merely a glasses prescription issue; high myopia carries serious long-term risks of retinal detachment, glaucoma, and macular degeneration.
Two or more hours of outdoor time daily is the most important preventive measure for delaying onset.
Once myopia has developed, active management with atropine, Ortho-K, or myopia control spectacle lenses significantly slows progression.
Combination therapy (atropine + Ortho-K) offers the strongest control effect currently available in Singapore.
Regular monitoring — every four to six months — with axial length measurement is the standard of care for any child on a myopia management programme.
Seek assessment from a qualified optometrist experienced in myopia management as early as possible after diagnosis.

For optometrists and optical shop owners in Singapore: CarrotByte's practice management platform includes dedicated examination templates for orthokeratology follow-ups and myopia management visits, helping you deliver organised, evidence-based care at scale. Learn more at carrotbyte.io.

Related Articles:

Atropine vs Orthokeratology for Myopia Control: A Complete Comparison